The European Investment Fund (EIF) recently joined as an investor in Carduso Capital, a new and independent fund for startups and innovative companies with roots in scientific research at the University of Groningen or the University Hospital (UMCG). Carduso Capital launched last year and with this EIF investment, the total fund has grown to €31 million.
For the EIF, this is the first investment in the Netherlands, in what is also known as a ‘Technology Transfer”; investing in funds related to leading scientific research institutes throughout Europe and the stimulation of transferring academic knowledge to startups. According to the EIF, the Groningen region offers more than enough opportunities and challenges to justify investments and stimulate the regional economy.
Seed and Early Stage Financing
Academic or knowledge institutions focussing on scientific research really benefit from financial support when new companies are founded based on that research, because it creates new jobs and strengthens the economy. The main objective of Carduso is to invest in new and innovative companies in the early stages of their growth and development, with their product not yet on the market, but do have an already proven concept. As a Seed and Early Stage investor, Carduso financing can be essential for startups in their early stages to continue to develop and grow.
Carduso Capital is an initiative of the University of Groningen and the University Hospitals (UMCG). The independent fund was founded in September of last year, and so far, the NOM, the Groningen University, the UMCG, Investment Fund Groningen, the Friesland Participation Fund and De Friesland Zorgverzekeraar have all contributed as investors.